Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Agenus Inc (AGEN)

Agenus Inc (AGEN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.70 -0.12 (-4.26%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.72 +0.02 (+0.74%) 17:03 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
2.67
Day High
3.00
Open 2.84
Previous Close 2.82 2.82
Volume 651,600 651,600
Avg Vol 750,470 750,470
Stochastic %K 69.80% 69.80%
Weighted Alpha -56.99 -56.99
5-Day Change +0.62 (+29.81%) +0.62 (+29.81%)
52-Week Range 1.38 - 19.69 1.38 - 19.69
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,482
  • Shares Outstanding, K 25,309
  • Annual Sales, $ 103,460 K
  • Annual Income, $ -227,210 K
  • EBIT $ -120 M
  • EBITDA $ -107 M
  • 60-Month Beta 1.58
  • Price/Sales 0.66
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 139.87% ( +8.07%)
  • Historical Volatility 122.52%
  • IV Percentile 41%
  • IV Rank 16.32%
  • IV High 452.62% on 11/12/24
  • IV Low 78.88% on 10/11/24
  • Put/Call Vol Ratio 0.21
  • Today's Volume 123
  • Volume Avg (30-Day) 419
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 9,345
  • Open Int (30-Day) 6,539

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.61
  • Number of Estimates 3
  • High Estimate -1.17
  • Low Estimate -1.85
  • Prior Year -3.04
  • Growth Rate Est. (year over year) +47.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.38 +95.65%
on 04/07/25
Period Open: 1.67
3.40 -20.59%
on 04/23/25
+1.03 (+61.68%)
since 03/25/25
3-Month
1.38 +95.65%
on 04/07/25
Period Open: 3.57
4.10 -34.15%
on 01/31/25
-0.87 (-24.37%)
since 01/24/25
52-Week
1.38 +95.65%
on 04/07/25
Period Open: 8.30
19.69 -86.29%
on 06/04/24
-5.60 (-67.47%)
since 04/25/24

Most Recent Stories

More News
Agenus (AGEN) Q4 2024 Earnings Call Transcript

AGEN earnings call for the period ending December 31, 2024.

AGEN : 2.70 (-4.26%)
Agenus: Q4 Earnings Snapshot

Agenus: Q4 Earnings Snapshot

AGEN : 2.70 (-4.26%)
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium

/CNW/ -- USA News Group News Commentary – Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January 23-25 in...

ONCY : 0.5562 (-4.65%)
AGEN : 2.70 (-4.26%)
GH : 48.30 (+1.88%)
XLO : 0.8285 (-1.13%)
ONC.TO : 0.77 (-4.94%)
RNXT : 0.9900 (-1.98%)
Agenus (AGEN) Q3 2024 Earnings Call Transcript

AGEN earnings call for the period ending September 30, 2024.

AGEN : 2.70 (-4.26%)
Agenus: Q3 Earnings Snapshot

Agenus: Q3 Earnings Snapshot

AGEN : 2.70 (-4.26%)
Agenus (AGEN) Q2 2024 Earnings Call Transcript

AGEN earnings call for the period ending June 30, 2024.

AGEN : 2.70 (-4.26%)
Agenus: Q2 Earnings Snapshot

Agenus: Q2 Earnings Snapshot

AGEN : 2.70 (-4.26%)
3 Magnificent Growth Stocks to Buy Hand Over Fist

Small-cap stocks could get a boost from the central bank's anticipated rate cuts in 2025. These three stocks may be a great way to get ahead of this catalyst.

AGEN : 2.70 (-4.26%)
LGND : 108.07 (-0.44%)
CURLF : 0.9540 (-1.88%)
CGC : 1.4100 (-5.37%)
Agenus (AGEN) Q1 2024 Earnings Call Transcript

AGEN earnings call for the period ending March 31, 2024.

AGEN : 2.70 (-4.26%)
Agenus: Q1 Earnings Snapshot

Agenus: Q1 Earnings Snapshot

AGEN : 2.70 (-4.26%)

Business Summary

Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's...

See More

Key Turning Points

3rd Resistance Point 3.24
2nd Resistance Point 3.12
1st Resistance Point 2.91
Last Price 2.70
1st Support Level 2.58
2nd Support Level 2.46
3rd Support Level 2.25

See More

52-Week High 19.69
Fibonacci 61.8% 12.69
Fibonacci 50% 10.53
Fibonacci 38.2% 8.37
Last Price 2.70
52-Week Low 1.38

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective